Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014)
Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, Moustafa Z, Scholz M, Lisboa B, Mohrmann S, Moebus V, Augustin D, Hoffmann G, Weiss E, Boehmer S, Kreienberg R, Du Bois A, Sattler D, Thomssen C, Kiechle M, Jaenicke F, Wallwiener D, Harbeck N, Kuhn W (2017)
Publication Type: Journal article
Publication year: 2017
Journal
Book Volume: 28
Pages Range: 2899-2899
Journal Issue: 11
Authors with CRIS profile
Arndt Hartmann
Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie
Ramona Erber
Institute of Pathology
Involved external institutions
Eberhard Karls Universität Tübingen
Germany (DE)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Germany (DE)
Westdeutsche Studiengruppe GmbH (WSG) / Women's healthcare Study Group
Germany (DE)
Heinrich-Heine-Universität Düsseldorf
Germany (DE)
St. Josefs-Hospital Wiesbaden
Germany (DE)
Technische Universität München (TUM)
Germany (DE)
Universitätsklinikum Bonn
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Donau Isar Klinikum
Germany (DE)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Klinikverbund Südwest (Sindelfingen-Böblingen, Calw, Nagold, Leonberg, Herrenberg)
Germany (DE)
HELIOS Kliniken
Germany (DE)
Evangelisches Krankenhaus Oberhausen
Germany (DE)
Trium Analysis Online GmbH
Germany (DE)
Germany (DE)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Germany (DE)
Westdeutsche Studiengruppe GmbH (WSG) / Women's healthcare Study Group
Germany (DE)
Heinrich-Heine-Universität Düsseldorf
Germany (DE)
St. Josefs-Hospital Wiesbaden
Germany (DE)
Technische Universität München (TUM)
Germany (DE)
Universitätsklinikum Bonn
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Donau Isar Klinikum
Germany (DE)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Klinikverbund Südwest (Sindelfingen-Böblingen, Calw, Nagold, Leonberg, Herrenberg)
Germany (DE)
HELIOS Kliniken
Germany (DE)
Evangelisches Krankenhaus Oberhausen
Germany (DE)
Trium Analysis Online GmbH
Germany (DE)
How to cite
APA:
Nitz, U., Gluz, O., Huober, J., Kreipe, H.H., Kates, R.E., Hartmann, A.,... Kuhn, W. (2017). Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014). Annals of Oncology, 28(11), 2899-2899. https://dx.doi.org/10.1093/annonc/mdw349
MLA:
Nitz, U., et al. "Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression (vol 25, pg 1551, 2014)." Annals of Oncology 28.11 (2017): 2899-2899.
BibTeX: Download